OS was applied for the output of clinical prognosis, and we found that high levels of SMC1A, SMC1B, SMC2, and SMC4 expression were significantly associated with poorer OS in HCC patients (Figure 4A). The gene discussed is SMC4; the disease is hepatocellular carcinoma.